A detailed history of Syon Capital LLC transactions in Novartis Ag stock. As of the latest transaction made, Syon Capital LLC holds 56,294 shares of NVS stock, worth $5.54 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares
56,294
Previous 58,364 3.55%
Holding current value
$5.54 Million
Previous $6.21 Billion 4.21%
% of portfolio
0.57%
Previous 0.57%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$106.13 - $120.89 $219,689 - $250,242
-2,070 Reduced 3.55%
56,294 $6.47 Billion
Q2 2024

Aug 13, 2024

SELL
$92.57 - $107.37 $25,641 - $29,741
-277 Reduced 0.47%
58,364 $6.21 Billion
Q1 2024

May 14, 2024

BUY
$95.27 - $108.47 $285,047 - $324,542
2,992 Added 5.38%
58,641 $5.67 Billion
Q4 2023

Feb 02, 2024

SELL
$92.27 - $101.54 $815,020 - $896,902
-8,833 Reduced 13.7%
55,649 $5.62 Billion
Q3 2023

Nov 03, 2023

BUY
$94.73 - $105.13 $6.11 Million - $6.78 Million
64,482 New
64,482 $6.57 Billion

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Syon Capital LLC Portfolio

Follow Syon Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Syon Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Syon Capital LLC with notifications on news.